胰岛素样肽5在直肠响应胆汁酸释放并与胆汁酸性腹泻患者的腹泻严重程度相关
本研究用新型免疫测定法检测人血INSL5,发现直肠灌注牛磺胆酸可快速升高血浆INSL5,健康志愿者INSL5水平低(<100 pg/mL)且混合餐后无变化;胆汁酸性腹泻患者INSL5升高且与平均粪便稠度正相关(p<0.001),腹泻型肠易激综合征患者中42%INSL5升高(>100 pg/mL),该亚组昂丹司琼治疗改善粪便稠度更明显(p<0.05)。
要点
- 直肠牛磺胆酸灌注可快速升高血浆INSL5,升高幅度与排便欲望正相关、与排便时间负相关。
- 健康志愿者INSL5水平低(<100 pg/mL),混合餐后无变化。
- 胆汁酸性腹泻患者INSL5升高,平均粪便稠度与血清INSL5正相关(p<0.001)。
核心结论
- 直肠胆汁酸刺激人INSL5分泌,INSL5水平与结肠促动力反应及慢性腹泻病理生理相关。
研究设计与样本
- 使用既往研究留存的血清/血浆样本,包括接受直肠牛磺胆酸灌肠的健康志愿者(n=7)、健康志愿者空腹及餐后样本(n=10)、胆汁酸性腹泻患者(n=19)或腹泻型肠易激综合征患者(n=8)、接受昂丹司琼或安慰剂治疗的腹泻型肠易激综合征患者(n=64)。
- 采用新型免疫测定法检测人血INSL5。
主要发现
- 直肠牛磺胆酸灌肠而非对照灌肠可快速升高血浆INSL5,INSL5升高与灌肠后排便时间呈负相关、与排便欲望呈正相关。
- 健康志愿者INSL5水平低(<100 pg/mL),混合餐后无变化。
- 胆汁酸性腹泻患者INSL5升高,平均粪便稠度与血清INSL5正相关(p<0.001)。
- 腹泻型肠易激综合征患者中42%INSL5升高(>100 pg/mL),该亚组昂丹司琼治疗粪便稠度改善更明显(p<0.05)。
关键数值与推荐
- 健康志愿者INSL5水平<100 pg/mL。
- 腹泻型肠易激综合征患者中INSL5升高定义为>100 pg/mL,占42%。
- 胆汁酸性腹泻患者平均粪便稠度与血清INSL5正相关(p<0.001)。
- INSL5升高亚组昂丹司琼治疗粪便稠度改善更明显(p<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insulin-like peptide 5 (INSL5) is an enteroendocrine hormone expressed in distal colonic 'L cells'. Bile acid receptor agonists are known to stimulate INSL5 secretion in primary cell culture, and administration of an INSL5 analogue in animals promotes colonic motility. OBJECTIVE: This study used a new immunoassay to measure INSL5 in human blood samples, enabling assessment of whether rectal bile acids stimulate INSL5 release in humans and whether INSL5 levels are altered in patients with chronic diarrhoea. DESIGN: Serum/plasma samples from previously performed studies were used, including healthy volunteers (n=7) who received a rectal enema of taurocholic acid (TCA); fasting and post prandial samples from healthy volunteers (n=10); patients with bile acid diarrhoea (BAD) (n=19) or irritable bowel syndrome with diarrhoea (IBS-D) (n=8); and patients with IBS-D (n=64) treated with ondansetron or placebo. RESULTS: Rectal TCA but not a control enema promptly elevated plasma INSL5, with the increase in INSL5 correlating negatively with time to, and positively with desire to, defecate post enema. Healthy volunteers had low INSL5 levels (<100 pg/mL), with no change following a mixed meal. Patients with BAD had elevated INSL5 levels, with average stool consistency being positively correlated with serum INSL5 (p<0.001). In people with IBS-D, INSL5 was elevated (>100 pg/mL) in 42%, and this subgroup showed greater improvements in stool consistency with ondansetron therapy (p<0.05). CONCLUSION: The study highlights that rectal bile acids stimulate INSL5 secretion in humans, and that INSL5 levels are associated with a colonic pro-motility response and pathophysiology of chronic diarrhoea.
引用
- Bannon CA, Walters JRF, Wu T, et al. Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea. Gut. 2026. PMID: 40701790. doi:10.1136/gutjnl-2025-335393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。